~Дженни~ wrote: Но, мамограмму назначили проходить каждый год.... Нужно ли?????Мне 42.
Согласно последним официальным evidence-based clinical guidelines , только Вы знаете на это ответ. До 40 - не нужно, после 50-надо, а в 40-49 - на усмотрение пациента (учитывая рекомендации лечащего врача, конечно).
The American College of Physicians (ACP) recommends tailoring the decision about screening for breast cancer in women aged 40 to 49 years based on the woman's concerns about mammography and breast cancer and her risk for breast cancer because of the associated benefits and risks for this age group....
Despite good evidence that mammography reduces mortality from breast cancer in 50- to 70-year-old women, mandating routine screening for women in this age group, evidence in younger women is conflicting. A 2002 meta-analysis by the US Preventive Services Task Force reviewed data from many clinical trials and estimated that screening mammography every 1 to 2 years in women aged 40 to 49 years was associated with a 15% decrease in breast cancer mortality after 14 years of follow-up. However, a separate Canadian study showed no benefit from mammography for women in this age group.
Reflecting the disparity in these findings, the US Preventive Services Task Force and the American College of Obstetricians and Gynecologists both recommend screening mammography every 1 to 2 years for women in the 40- to 49-year-old age group, whereas the 2006 American Cancer Society guideline recommends yearly mammograms beginning at age 40 years...
The decision of whether to perform screening mammography among women 40 to 49 years of age should be individualized for each patient. The 5-year risk of developing breast cancer at these ages can range from 0.4% to 6%. Women in this age range who have the following risk factors carry a higher risk for breast cancer vs women who are 50 years of age:
2 first-degree relatives with breast cancer
2 previous breast biopsies
1 first-degree relative with breast cancer plus 1 previous breast biopsy
Previous diagnosis of breast cancer, atypical hyperplasia, or ductal carcinoma in situ
Previous chest irradiation
BRCA1 or BRCA2 mutation
The risk assessment for breast cancer for each patient should be reevaluated every 1 to 2 years. Risk assessment tools, such as the Gail model, are limited in aiding clinicians and patients to make individualized decisions regarding screening mammography.
Clinicians should inform patients of the potential benefits and harms of screening mammography, particularly the reduction in breast-cancer–associated mortality and high false-positive rates of screening.
...Beside the risk for false-positive tests, pain is another negative factor weighing against the decision to perform screening mammography in younger women. Up to 77% of women report pain associated with the procedure. Other negative consequences of screening mammography include exposure to radiation and anxiety. http://www.medscape.com/viewarticle/554473
